^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CTA30X UCAR-T

i
Other names: CTA30X UCAR-T
Associations
Trials
Company:
Nanjing Bioheng Biotech
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials